Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect
ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Figure 1Loading Img
RETURN TO ISSUEPREVResearch ArticleNEXT

Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties

View Author Information
Neuroscience Medicinal Chemistry, Pfizer PharmaTherapeutics Research and Development, 558 Eastern Point Road, Groton, Connecticut 06340
*Tel: 860-715-4059. Fax: 860-686-6052. E-mail: [email protected]
Cite this: ACS Chem. Neurosci. 2010, 1, 6, 435–449
Publication Date (Web):March 25, 2010
https://doi.org/10.1021/cn100008c
Copyright © 2010 American Chemical Society

    Article Views

    18219

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options
    Supporting Info (2)»

    Abstract

    Abstract Image

    The interplay among commonly used physicochemical properties in drug design was examined and utilized to create a prospective design tool focused on the alignment of key druglike attributes. Using a set of six physicochemical parameters ((a) lipophilicity, calculated partition coefficient (ClogP); (b) calculated distribution coefficient at pH = 7.4 (ClogD); (c) molecular weight (MW); (d) topological polar surface area (TPSA); (e) number of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compounds (N = 11 303). The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0−6), in comparison to 60% of the Pfizer CNS candidates. This analysis suggests that this algorithm could potentially be used to identify compounds with a higher probability of successfully testing hypotheses in the clinic. In addition, a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set. The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure−activity relationships (SAR) by expanding medicinal chemistry design space through a holistic assessment approach. Based on six physicochemical properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compounds with increased probability of success.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    CNS MPO component and desirability scores for drugs (119) and candidates (108) and CNS MPO desirability distribution plot for drug with target class labeled. This material is available free of charge via the Internet at http://pubs.acs.org.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 748 publications.

    1. Alexandra Ioana Corfu, Nuno Santarem, Sara Luelmo, Gaia Mazza, Alessandro Greco, Alessandra Altomare, Giulio Ferrario, Giulia Nasta, Oliver Keminer, Giancarlo Aldini, Lucia Tamborini, Nicoletta Basilico, Silvia Parapini, Sheraz Gul, Anabela Cordeiro-da-Silva, Paola Conti, Chiara Borsari. Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents. ACS Infectious Diseases 2024, 10 (6) , 2222-2238. https://doi.org/10.1021/acsinfecdis.4c00181
    2. Chloe C. Ence, Taher Uddin, Julien Borrel, Payal Mittal, Han Xie, Jochen Zoller, Amit Sharma, Eamon Comer, Stuart L. Schreiber, Bruno Melillo, L. David Sibley, Arnab K. Chatterjee. Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure. ACS Infectious Diseases 2024, 10 (6) , 2212-2221. https://doi.org/10.1021/acsinfecdis.4c00170
    3. Faridoon, Jiyue Zheng, Tao Zhang, Shuilong Tong, Tao Liu, Jiuen Cui, Haojie Xu, Di Hu, Ying Shen, Yajing Yin, Danhua Zhao, Chensheng Tan, Xue Dong, Jiali Chen, Feihong Ji, Chenhua Tong, Jie Jack Li, Jiapeng Li, Guiping Zhang. Structure-Based Design and Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High Selectivity, Brain Penetration, and In Vivo Efficacy. Journal of Medicinal Chemistry 2024, 67 (11) , 9431-9446. https://doi.org/10.1021/acs.jmedchem.4c00552
    4. Ute Christmann, Lourdes Garriga, Ana Virginia Llorente, José Luis Díaz, Rosalía Pascual, Magda Bordas, Albert Dordal, Mónica Porras, Sandra Yeste, Raquel F. Reinoso, José Miguel Vela, Carmen Almansa. WLB-87848, a Selective σ1 Receptor Agonist, with an Unusually Positioned NH Group as Positive Ionizable Moiety and Showing Neuroprotective Activity. Journal of Medicinal Chemistry 2024, 67 (11) , 9150-9164. https://doi.org/10.1021/acs.jmedchem.4c00288
    5. Martin Pettersson, Douglas S. Johnson, John M. Humphrey, Christopher W. am Ende, Todd W. Butler, Peter H. Dorff, Ivan V. Efremov, Edelweiss Evrard, Michael E. Green, Christopher J. Helal, Gregory W. Kauffman, Patrick B. Mullins, Thayalan Navaratnam, Christopher J. O’Donnell, Theresa J. O’Sullivan, Nandini C. Patel, Antonia F. Stepan, Cory M. Stiff, Chakrapani Subramanyam, Patrick Trapa, Tuan P. Tran, Beth Cooper Vetelino, Eddie Yang, Longfei Xie, Leslie R. Pustilnik, Stefanus J. Steyn, Kathleen M. Wood, Kelly R. Bales, Eva Hajos-Korcsok, Patrick R. Verhoest. Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry 2024, Article ASAP.
    6. Francesco Rianjongdee, David Palmer, Stephen D. Pickett, Peter Pogány, Nicholas C. O. Tomkinson, Darren V. S. Green. bbSelect – An Open-Source Tool for Performing a 3D Pharmacophore-Driven Diverse Selection of R-Groups. Journal of Chemical Information and Modeling 2024, Article ASAP.
    7. Martin K. Himmelbauer, Bekim Bajrami, Rebecca Basile, Andrew Capacci, TeYu Chen, Colin K. Choi, Rab Gilfillan, Felix Gonzalez-Lopez de Turiso, Chungang Gu, Marc Hoemberger, Douglas S. Johnson, J. Howard Jones, Ekta Kadakia, Melissa Kirkland, Edward Y. Lin, Ying Liu, Bin Ma, Tom Magee, Srinivasa Mantena, Isaac E. Marx, Claire M. Metrick, Michael Mingueneau, Paramasivam Murugan, Cathy A. Muste, Prasad Nadella, Marta Nevalainen, Chelsea R. Parker Harp, Vatee Pattaropong, Alicia Pietrasiewicz, Robin J. Prince, Thomas J. Purgett, Joseph C. Santoro, Jurgen Schulz, Simone Sciabola, Hao Tang, H. George Vandeveer, Ti Wang, Zain Yousaf, Christopher J. Helal, Brian T. Hopkins. Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis. Journal of Medicinal Chemistry 2024, 67 (10) , 8122-8140. https://doi.org/10.1021/acs.jmedchem.4c00220
    8. Md. Shafikur Rahman, Shiva Hadi Esfahani, Yong Zhang, Aarfa Queen, Manar Aljarrah, Haya Kandil, Andrew Baez, Thomas J. Abbruscato, Vardan T. Karamyan, Paul C. Trippier. Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability. ACS Medicinal Chemistry Letters 2024, 15 (4) , 510-517. https://doi.org/10.1021/acsmedchemlett.4c00009
    9. Dahlia R. Weiss, Javier L. Baylon, Ethan D. Evans, Anthony Paiva, Gerry Everlof, Jingfang Cutrone, Fabio Broccatelli. Balanced Permeability Index: A Multiparameter Index for Improved In Vitro Permeability. ACS Medicinal Chemistry Letters 2024, 15 (4) , 457-462. https://doi.org/10.1021/acsmedchemlett.3c00542
    10. Gaofeng Lin, Qinlong Xu, Jiaming Li, Zhaoxing Chu, Xiaodong Ma, Qihua Zhu, Yan Zhao, Jiajia Mo, Wenfeng Ye, Li Shao, Tao Fang, Minghan He, Shaoyun Yue, Mingqi Dai. Design, Synthesis, and Biological Evaluation of Pierardine Derivatives as Novel Brain-Penetrant and In Vivo Potent NMDAR-GluN2B Antagonists for Ischemic Stroke Treatment. Journal of Medicinal Chemistry 2024, 67 (5) , 3358-3384. https://doi.org/10.1021/acs.jmedchem.3c01524
    11. Kurt G. Pike, Thomas A. Hunt, Bernard Barlaam, David Benstead, Elaine Cadogan, Kan Chen, Calum R. Cook, Nicola Colclough, Chao Deng, Stephen T. Durant, Andrew Eatherton, Kristin Goldberg, Peter Johnström, Libin Liu, Zhaoqun Liu, J. Willem M. Nissink, Chengling Pang, Martin Pass, Graeme R. Robb, Caroline Roberts, Magnus Schou, Oliver Steward, Andy Sykes, Yumei Yan, Baochang Zhai, Li Zheng. Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood–Brain Barrier: The Discovery of AZD1390. Journal of Medicinal Chemistry 2024, 67 (4) , 3090-3111. https://doi.org/10.1021/acs.jmedchem.3c02277
    12. Therese C. Ku, Jianjing Cao, Sung Joon Won, Jiqing Guo, Gisela A. Camacho-Hernandez, Amarachi V. Okorom, Kristine Walloe Salomon, Kuo Hao Lee, Claus J. Loland, Henry J. Duff, Lei Shi, Amy Hauck Newman. Series of (([1,1′-Biphenyl]-2-yl)methyl)sulfinylalkyl Alicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter Inhibitors with Reduced hERG Activity. ACS Pharmacology & Translational Science 2024, 7 (2) , 515-532. https://doi.org/10.1021/acsptsci.3c00322
    13. Louis G. Mueller, Barbara S. Slusher, Takashi Tsukamoto. Empirical Analysis of Drug Targets for Nervous System Disorders. ACS Chemical Neuroscience 2024, 15 (3) , 394-399. https://doi.org/10.1021/acschemneuro.3c00676
    14. Suzanne M. Szewczyk, Isha Verma, Jacob T. Edwards, Dahlia R. Weiss, Eugene L. P. Chekler. Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores. Journal of Medicinal Chemistry 2024, 67 (2) , 1327-1335. https://doi.org/10.1021/acs.jmedchem.3c01872
    15. Amarachi V. Okorom, Gisela Andrea Camacho-Hernandez, Kristine Salomon, Kuo Hao Lee, Therese C. Ku, Jianjing Cao, Sung Joon Won, Jacob Friedman, Jenny Lam, James Paule, Rana Rais, Benjamin Klein, Zheng-Xiong Xi, Lei Shi, Claus J. Loland, Amy Hauck Newman. Modifications to 1-(4-(2-Bis(4-fluorophenyl)methyl)sulfinyl)alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile. Journal of Medicinal Chemistry 2024, 67 (1) , 709-727. https://doi.org/10.1021/acs.jmedchem.3c02037
    16. Mausam Kalita, Jun Hyung Park, Renesmee Chenting Kuo, Samira Hayee, Sara Marsango, Valentina Straniero, Israt S. Alam, Angelie Rivera-Rodriguez, Mallesh Pandrala, Mackenzie L. Carlson, Samantha T. Reyes, Isaac M. Jackson, Lorenzo Suigo, Audrey Luo, Sydney C. Nagy, Ermanno Valoti, Graeme Milligan, Frezghi Habte, Bin Shen, Michelle L. James. PET Imaging of Innate Immune Activation Using 11C Radiotracers Targeting GPR84. JACS Au 2023, 3 (12) , 3297-3310. https://doi.org/10.1021/jacsau.3c00435
    17. Jarvis Hill, Robert M. Jones, David Crich. Discovery of a Hydroxylamine-Based Brain-Penetrant EGFR Inhibitor for Metastatic Non-Small-Cell Lung Cancer. Journal of Medicinal Chemistry 2023, 66 (22) , 15477-15492. https://doi.org/10.1021/acs.jmedchem.3c01669
    18. Andrew A. BolingerNoelle C. AnastasioKathryn A. CunninghamJia Zhou. THE SEROTONIN 5-HT2A RECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET. , 53-81. https://doi.org/10.1021/mc-2023-vol58.ch03
    19. Craig E. Stivala, Domagoj Vucic. RECENT DEVELOPMENTS IN THE DISCOVERY OF BRAIN-PENETRANT RIP1 INHIBITORS. , 83-102. https://doi.org/10.1021/mc-2023-vol58.ch04
    20. Mintesinot Kassu, Prakash T. Parvatkar, Jillian Milanes, Neil P. Monaghan, Chungsik Kim, Matthew Dowgiallo, Yingzhao Zhao, Ami H. Asakawa, Lili Huang, Alicia Wagner, Brandon Miller, Karissa Carter, Kayleigh F. Barrett, Logan M. Tillery, Lynn K. Barrett, Isabelle Q. Phan, Sandhya Subramanian, Peter J. Myler, Wesley C. Van Voorhis, James W. Leahy, Christopher A. Rice, Dennis E. Kyle, James Morris, Roman Manetsch. Shotgun Kinetic Target-Guided Synthesis Approach Enables the Discovery of Small-Molecule Inhibitors against Pathogenic Free-Living Amoeba Glucokinases. ACS Infectious Diseases 2023, 9 (11) , 2190-2201. https://doi.org/10.1021/acsinfecdis.3c00284
    21. E. Johanna L. Stéen, A Yeong Park, Wissam Beaino, Changdev Gorakshnath Gadhe, Esther Kooijman, Robert C. Schuit, Maxime Schreurs, Prisca Leferink, Jeroen J. M. Hoozemans, Jae Eun Kim, Jinhwa Lee, Albert D. Windhorst. Development of 18F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson’s Disease. Journal of Medicinal Chemistry 2023, 66 (18) , 12990-13006. https://doi.org/10.1021/acs.jmedchem.3c00902
    22. Ute Christmann, José Luis Díaz, Rosalia Pascual, Magda Bordas, Inés Álvarez, Xavier Monroy, Mónica Porras, Sandra Yeste, Raquel F. Reinoso, Manuel Merlos, José Miguel Vela, Carmen Almansa. Discovery of WLB-89462, a New Drug-like and Highly Selective σ2 Receptor Ligand with Neuroprotective Properties. Journal of Medicinal Chemistry 2023, 66 (17) , 12499-12519. https://doi.org/10.1021/acs.jmedchem.3c01060
    23. Adriana Di Nanni, Ran Sing Saw, Umberto M. Battisti, Gregory D. Bowden, Adam Boeckermann, Kaare Bjerregaard-Andersen, Bernd J. Pichler, Kristina Herfert, Matthias M. Herth, Andreas Maurer. A Fluorescent Probe as a Lead Compound for a Selective α-Synuclein PET Tracer: Development of a Library of 2-Styrylbenzothiazoles and Biological Evaluation of [18F]PFSB and [18F]MFSB. ACS Omega 2023, 8 (34) , 31450-31467. https://doi.org/10.1021/acsomega.3c04292
    24. Alessandro Bonifazi, Elizabeth Saab, Julie Sanchez, Antonina L. Nazarova, Saheem A. Zaidi, Khorshada Jahan, Vsevolod Katritch, Meritxell Canals, J. Robert Lane, Amy Hauck Newman. Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics. Journal of Medicinal Chemistry 2023, 66 (15) , 10304-10341. https://doi.org/10.1021/acs.jmedchem.3c00417
    25. Dhananjayan Vasu, Ha T. Do, Huiying Li, Christine D. Hardy, Amardeep Awasthi, Thomas L. Poulos, Richard B. Silverman. Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors. Journal of Medicinal Chemistry 2023, 66 (14) , 9934-9953. https://doi.org/10.1021/acs.jmedchem.3c00782
    26. Jianping Chen, Erik J. Garcia, Christina R. Merritt, Joshua C. Zamora, Andrew A. Bolinger, Konrad Pazdrak, Susan J. Stafford, Randy C. Mifflin, Eric A. Wold, Christopher T. Wild, Haiying Chen, Noelle C. Anastasio, Kathryn A. Cunningham, Jia Zhou. Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT2C Receptor and Dual 5-HT2C/5-HT2A Receptor Modulators. Journal of Medicinal Chemistry 2023, 66 (14) , 9992-10009. https://doi.org/10.1021/acs.jmedchem.3c00908
    27. Robert I. Horne, Mhd Hussein Murtada, Donghui Huo, Z. Faidon Brotzakis, Rebecca C. Gregory, Andrea Possenti, Sean Chia, Michele Vendruscolo. Exploration and Exploitation Approaches Based on Generative Machine Learning to Identify Potent Small Molecule Inhibitors of α-Synuclein Secondary Nucleation. Journal of Chemical Theory and Computation 2023, 19 (14) , 4701-4710. https://doi.org/10.1021/acs.jctc.2c01303
    28. Iacovos N. Michaelides, Gavin W. Collie, Ulf Börjesson, Christina Vasalou, Omar Alkhatib, Louise Barlind, Tony Cheung, Ian L. Dale, Kevin J. Embrey, Edward J. Hennessy, Puneet Khurana, Cheryl M. Koh, Michelle L. Lamb, Jianming Liu, Thomas A. Moss, Daniel J. O’Neill, Christopher Phillips, Joseph Shaw, Arjan Snijder, R. Ian Storer, Christopher J. Stubbs, Fujin Han, Chengzhi Li, Jingchuan Qiao, Dong-Qing Sun, Jingwen Wang, Peng Wang, Wenzhen Yang. Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor. Journal of Medicinal Chemistry 2023, 66 (13) , 8782-8807. https://doi.org/10.1021/acs.jmedchem.3c00401
    29. Jason G. Kettle, Sharan K. Bagal, Derek Barratt, Michael S. Bodnarchuk, Scott Boyd, Erin Braybrooke, Jason Breed, Doyle J. Cassar, Sabina Cosulich, Michael Davies, Nichola L. Davies, Chao Deng, Andrew Eatherton, Laura Evans, Lyman J. Feron, Shaun Fillery, Emma S. Gleave, Frederick W. Goldberg, Miguel A. Cortés González, Carine Guerot, Afreen Haider, Stephanie Harlfinger, Rachel Howells, Anne Jackson, Peter Johnström, Paul D. Kemmitt, Alex Koers, Mikhail Kondrashov, Gillian M. Lamont, Scott Lamont, Hilary J. Lewis, Libin Liu, Megan Mylrea, Samuel Nash, Michael J. Niedbala, Alison Peter, Christopher Phillips, Kurt Pike, Piotr Raubo, Graeme R. Robb, Sarah Ross, Matthew G. Sanders, Magnus Schou, Iain Simpson, Oliver Steward. Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration. Journal of Medicinal Chemistry 2023, 66 (13) , 9147-9160. https://doi.org/10.1021/acs.jmedchem.3c00746
    30. Morgan Lawrenz, Mats Svensson, Mitsunori Kato, Karen H. Dingley, Jackson Chief Elk, Zhe Nie, Yefen Zou, Zachary Kaplan, H. Rachel Lagiakos, Hideyuki Igawa, Eric Therrien. A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, Kp,uu. Journal of Chemical Information and Modeling 2023, 63 (12) , 3786-3798. https://doi.org/10.1021/acs.jcim.3c00150
    31. Richard A. Hartz, Vijay T. Ahuja, Guanglin Luo, Ling Chen, Prasanna Sivaprakasam, Hong Xiao, Carol M. Krause, Wendy J. Clarke, Songmei Xu, John S. Tokarski, Kevin Kish, Hal Lewis, Nicolas Szapiel, Ramu Ravirala, Sayali Mutalik, Deepa Nakmode, Devang Shah, Catherine R. Burton, John E. Macor, Gene M. Dubowchik. Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors. Journal of Medicinal Chemistry 2023, 66 (11) , 7534-7552. https://doi.org/10.1021/acs.jmedchem.3c00364
    32. Fleur M.G. Cornelissen, Greta Markert, Ghislaine Deutsch, Maria Antonara, Noa Faaij, Imke Bartelink, David Noske, W. Peter Vandertop, Andreas Bender, Bart A. Westerman. Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms. Journal of Medicinal Chemistry 2023, 66 (11) , 7253-7267. https://doi.org/10.1021/acs.jmedchem.2c01824
    33. Melissa Chassé, Neil Vasdev. Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [11C]Talmapimod: Effects of Drug Efflux and Sex Differences. ACS Chemical Neuroscience 2023, 14 (11) , 2193-2200. https://doi.org/10.1021/acschemneuro.3c00205
    34. Lin Qiu, Hao Jiang, Charles Zhou, Jinzhi Wang, Yanbo Yu, Haiyang Zhao, Tianyu Huang, Robert Gropler, Joel S. Perlmutter, Tammie L. S. Benzinger, Zhude Tu. Discovery of a Promising Fluorine-18 Positron Emission Tomography Radiotracer for Imaging Sphingosine-1-Phosphate Receptor 1 in the Brain. Journal of Medicinal Chemistry 2023, 66 (7) , 4671-4688. https://doi.org/10.1021/acs.jmedchem.2c01752
    35. Eddie Yang, Joseph W. Tucker, Thomas A. Chappie, John D. Weaver, Caroline Chapman, Remzi Duzguner, John M. Humphrey. Synthesis of a Pyridoazepine Scaffold via Rhodium-Catalyzed Ring Expansion and Nitroacetamide Condensation. Organic Process Research & Development 2023, 27 (2) , 248-255. https://doi.org/10.1021/acs.oprd.2c00145
    36. Emma S. Gogarnoiu, Caleb D. Vogt, Julie Sanchez, Alessandro Bonifazi, Elizabeth Saab, Anver Basha Shaik, Omar Soler-Cedeño, Guo-Hua Bi, Benjamin Klein, Zheng-Xiong Xi, J. Robert Lane, Amy Hauck Newman. Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders. Journal of Medicinal Chemistry 2023, 66 (3) , 1809-1834. https://doi.org/10.1021/acs.jmedchem.2c01624
    37. Baljinder Singh, Amrita Sharma, Naresh Gunaganti, Mitch Rivers, Pradip K. Gadekar, Brady Greene, Michael Chichioco, Carlos E. Sanz-Rodriguez, Courtney Fu, Catherine LeBlanc, Erin Burchfield, Nyle Sharif, Benjamin Hoffman, Gaurav Kumar, Andrei Purmal, Kojo Mensa-Wilmot, Michael P. Pollastri. Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery. Journal of Medicinal Chemistry 2023, 66 (3) , 1972-1989. https://doi.org/10.1021/acs.jmedchem.2c01767
    38. Meijuan Jiang, Shuiyu Lu, Sanjay Telu, Victor W. Pike. An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands. Journal of Medicinal Chemistry 2023, 66 (2) , 1543-1561. https://doi.org/10.1021/acs.jmedchem.2c01745
    39. Sean Chia, Z. Faidon Brotzakis, Robert I. Horne, Andrea Possenti, Benedetta Mannini, Rodrigo Cataldi, Magdalena Nowinska, Roxine Staats, Sara Linse, Tuomas P. J. Knowles, Johnny Habchi, Michele Vendruscolo. Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates. Molecular Pharmaceutics 2023, 20 (1) , 183-193. https://doi.org/10.1021/acs.molpharmaceut.2c00548
    40. Nicole D. Bartolo, Niall Mortimer, Mariah A. Manter, Nicholas Sanchez, Misha Riley, Tiernan T. O’Malley, Jacob M. Hooker. Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer’s Disease. ACS Chemical Neuroscience 2022, 13 (24) , 3641-3660. https://doi.org/10.1021/acschemneuro.2c00607
    41. Erin L. ColeLindsey R. Drake. POSITRON EMISSION TOMOGRAPHY NEUROIMAGING IN DRUG DISCOVERY AND DEVELOPMENT. , 61-90. https://doi.org/10.1021/mc-2022-vol57.ch03
    42. Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Masahiro Ono. Synthesis and Evaluation of 18F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model. ACS Chemical Neuroscience 2022, 13 (20) , 2982-2990. https://doi.org/10.1021/acschemneuro.2c00473
    43. Mari Nakaie, Fumihiro Katayama, Takehiro Nakagaki, Sakura Yoshida, Masao Kawasaki, Kodai Nishi, Kazuma Ogawa, Akira Toriba, Noriyuki Nishida, Morio Nakayama, Takeshi Fuchigami. Synthesis and Biological Evaluation of Novel 2-(Benzofuran-2-yl)-chromone Derivatives for In Vivo Imaging of Prion Deposits in the Brain. ACS Infectious Diseases 2022, 8 (9) , 1869-1882. https://doi.org/10.1021/acsinfecdis.2c00142
    44. Sarah Huff, Indrasena Reddy Kummetha, Lingzhi Zhang, Lingling Wang, William Bray, Jiekai Yin, Vanessa Kelley, Yinsheng Wang, Tariq M. Rana. Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents. Journal of Medicinal Chemistry 2022, 65 (16) , 10920-10937. https://doi.org/10.1021/acs.jmedchem.1c02075
    45. Claudia Albertini, Alessandra Salerno, Silvia Atzeni, Elisa Uliassi, Francesca Massenzio, Annalisa Maruca, Roberta Rocca, Marko Mecava, Filomena S. G. Silva, Débora Mena, Pedro Valente, Ana I. Duarte, Daniel Chavarria, Maicol Bissaro, Stefano Moro, Stephanie Federico, Giampiero Spalluto, Ondřej Soukup, Fernanda Borges, Stefano Alcaro, Barbara Monti, Paulo J. Oliveira, Josè C. Menéndez, Maria Laura Bolognesi. Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis. ACS Chemical Neuroscience 2022, 13 (15) , 2252-2260. https://doi.org/10.1021/acschemneuro.2c00261
    46. Tammy Ladduwahetty, Matthew R. Lee, Michel C. Maillard, Roger Cachope, Daniel Todd, Michael Barnes, Vahri Beaumont, Alka Chauhan, Caroline Gallati, Alan F. Haughan, Georg Kempf, Christopher A. Luckhurst, Kim Matthews, George McAllister, Philip Mitchell, Hiral Patel, Mark Rose, Elizabeth Saville-Stones, Stefan Steinbacher, Andrew J. Stott, Emma Thatcher, Jason Tierney, Liudvikas Urbonas, Ignacio Munoz-Sanjuan, Celia Dominguez. Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington’s Disease. Journal of Medicinal Chemistry 2022, 65 (14) , 9819-9845. https://doi.org/10.1021/acs.jmedchem.2c00474
    47. Ahmed Morsy, Krishnaiah Maddeboina, Ju Gao, Hezhen Wang, Juan Valdez, Louise F. Dow, Xinglong Wang, Paul C. Trippier. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction. ACS Chemical Neuroscience 2022, 13 (14) , 2176-2190. https://doi.org/10.1021/acschemneuro.2c00246
    48. Aya M. Kelly, Matthew R. Berry, Sarah Z. Tasker, Sydney A. McKee, Timothy M. Fan, Paul J. Hergenrother. Target-Agnostic P-Glycoprotein Assessment Yields Strategies to Evade Efflux, Leading to a BRAF Inhibitor with Intracranial Efficacy. Journal of the American Chemical Society 2022, 144 (27) , 12367-12380. https://doi.org/10.1021/jacs.2c03944
    49. Seid Hamzic, Richard Lewis, Sandrine Desrayaud, Cihan Soylu, Mike Fortunato, Grégori Gerebtzoff, Raquel Rodríguez-Pérez. Predicting In Vivo Compound Brain Penetration Using Multi-task Graph Neural Networks. Journal of Chemical Information and Modeling 2022, 62 (13) , 3180-3190. https://doi.org/10.1021/acs.jcim.2c00412
    50. Yuguang Zhao, William Mahy, Nicky J. Willis, Hannah L. Woodward, David Steadman, Elliott D. Bayle, Benjamin N. Atkinson, James Sipthorp, Luca Vecchia, Reinis R. Ruza, Karl Harlos, Fiona Jeganathan, Stefan Constantinou, Artur Costa, Svend Kjær, Magda Bictash, Patricia C. Salinas, Paul Whiting, Jean-Paul Vincent, Paul V. Fish, E. Yvonne Jones. Structural Analysis and Development of Notum Fragment Screening Hits. ACS Chemical Neuroscience 2022, 13 (13) , 2060-2077. https://doi.org/10.1021/acschemneuro.2c00325
    51. Isaac M. Jackson, E. William Webb, Peter J.H. Scott, Michelle L. James. In Silico Approaches for Addressing Challenges in CNS Radiopharmaceutical Design. ACS Chemical Neuroscience 2022, 13 (12) , 1675-1683. https://doi.org/10.1021/acschemneuro.2c00269
    52. Nicky J. Willis, William Mahy, James Sipthorp, Yuguang Zhao, Hannah L. Woodward, Benjamin N. Atkinson, Elliott D. Bayle, Fredrik Svensson, Sarah Frew, Fiona Jeganathan, Amy Monaghan, Stefano Benvegnù, Sarah Jolly, Luca Vecchia, Reinis R. Ruza, Svend Kjær, Steven Howell, Ambrosius P. Snijders, Magda Bictash, Patricia C. Salinas, Jean-Paul Vincent, E. Yvonne Jones, Paul Whiting, Paul V. Fish. Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit. Journal of Medicinal Chemistry 2022, 65 (10) , 7212-7230. https://doi.org/10.1021/acs.jmedchem.2c00162
    53. Brian Goldman, Steven Kearnes, Trevor Kramer, Patrick Riley, W. Patrick Walters. Defining Levels of Automated Chemical Design. Journal of Medicinal Chemistry 2022, 65 (10) , 7073-7087. https://doi.org/10.1021/acs.jmedchem.2c00334
    54. Hussein Bdair, Thomas A. Singleton, Karen Ross, Dean Jolly, Min Su Kang, Arturo Aliaga, Marius Tuznik, Tanpreet Kaur, Saïd Yous, Jean-Paul Soucy, Gassan Massarweh, Peter J. H. Scott, Robert Koeppe, Gilberto Spadoni, Annalida Bedini, David A. Rudko, Gabriella Gobbi, Chawki Benkelfat, Pedro Rosa-Neto, Allen F. Brooks, Alexey Kostikov. Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors. ACS Chemical Neuroscience 2022, 13 (9) , 1382-1394. https://doi.org/10.1021/acschemneuro.1c00678
    55. Ho Young Kim, Ji Youn Lee, Chia-Ju Hsieh, Aladdin Riad, Nicholas J. Izzo, Susan M. Catalano, Thomas J. A. Graham, Robert H. Mach. Screening of σ2 Receptor Ligands and In Vivo Evaluation of 11C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ2 Receptor Brain PET Tracer. Journal of Medicinal Chemistry 2022, 65 (8) , 6261-6272. https://doi.org/10.1021/acs.jmedchem.2c00191
    56. R. Rama Suresh, Zhan-Guo Gao, Veronica Salmaso, Eric Chen, Ryan G. Campbell, Russell B. Poe, Theodore E. Liston, Kenneth A. Jacobson. Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species. ACS Medicinal Chemistry Letters 2022, 13 (4) , 623-631. https://doi.org/10.1021/acsmedchemlett.1c00685
    57. Jacob P. Sorrentino, Ryan A. Altman. Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability. ACS Medicinal Chemistry Letters 2022, 13 (4) , 707-713. https://doi.org/10.1021/acsmedchemlett.2c00055
    58. Kirandeep Samby, Dominique Besson, Anirban Dutta, Buddhadev Patra, Angelique Doy, Paul Glossop, James Mills, Gavin Whitlock, Rob Hooft van Huijsduijnen, Alessandra Monaco, Graeme Bilbe, Charles Mowbray, Benjamin Perry, Anna Adam, Timothy N. C. Wells, Paul A. Willis. The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks. ACS Infectious Diseases 2022, 8 (4) , 713-720. https://doi.org/10.1021/acsinfecdis.1c00527
    59. Boshi Huang, Mengchu Li, Pornprom Klongkumnuankarn, Rolando E. Mendez, James C. Gillespie, David L. Stevens, William L. Dewey, Dana E. Selley, Yan Zhang. Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment. Journal of Medicinal Chemistry 2022, 65 (6) , 4991-5003. https://doi.org/10.1021/acs.jmedchem.1c02185
    60. Piyusha P. Pagare, Mengchu Li, Yi Zheng, Abhishek S. Kulkarni, Samuel Obeng, Boshi Huang, Christian Ruiz, James C. Gillespie, Rolando E. Mendez, David L. Stevens, Justin L. Poklis, Matthew S. Halquist, William L. Dewey, Dana E. Selley, Yan Zhang. Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists. Journal of Medicinal Chemistry 2022, 65 (6) , 5095-5112. https://doi.org/10.1021/acs.jmedchem.2c00087
    61. Keigo Hirai, Hiroko Yamashita, Shusuke Tomoshige, Yugo Mishima, Tatsuya Niwa, Kenji Ohgane, Mayumi Ishii, Kayoko Kanamitsu, Yui Ikemi, Shinsaku Nakagawa, Hideki Taguchi, Shinichi Sato, Yuichi Hashimoto, Minoru Ishikawa. Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties. ACS Medicinal Chemistry Letters 2022, 13 (3) , 396-402. https://doi.org/10.1021/acsmedchemlett.1c00500
    62. José Jiménez-Luna, Miha Skalic, Nils Weskamp. Benchmarking Molecular Feature Attribution Methods with Activity Cliffs. Journal of Chemical Information and Modeling 2022, 62 (2) , 274-283. https://doi.org/10.1021/acs.jcim.1c01163
    63. David Steadman, Benjamin N. Atkinson, Yuguang Zhao, Nicky J. Willis, Sarah Frew, Amy Monaghan, Chandni Patel, Emma Armstrong, Kathryn Costelloe, Lorenza Magno, Magda Bictash, E. Yvonne Jones, Paul V. Fish, Fredrik Svensson. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. Journal of Medicinal Chemistry 2022, 65 (1) , 562-578. https://doi.org/10.1021/acs.jmedchem.1c01735
    64. Christian Jorgensen, Martin B. Ulmschneider, Peter C. Searson. Atomistic Model of Solute Transport across the Blood–Brain Barrier. ACS Omega 2022, 7 (1) , 1100-1112. https://doi.org/10.1021/acsomega.1c05679
    65. Berend van der Wildt, Bieneke Janssen, Aleksandra Pekošak, E. Johanna L. Stéen, Robert C. Schuit, Esther J. M. Kooijman, Wissam Beaino, Danielle J. Vugts, Albert D. Windhorst. Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain. ACS Chemical Neuroscience 2021, 12 (23) , 4465-4474. https://doi.org/10.1021/acschemneuro.1c00641
    66. J. Howard Jones, Zhili Xin, Martin Himmelbauer, Michael Dechantsreiter, Istvan Enyedy, Joseph Hedde, Terry Fang, Janaky Coomaraswamy, Kristopher W. King, Paramasivam Murugan, Joseph C. Santoro, Thomas Hesson, Dirk M. Walther, Ru Wei, Fengmei Zheng, Douglas J. Marcotte, Kerri Spilker, P. Rajesh Kumar, Ying Liu, Rab Gilfillan, Felix Gonzalez-Lopez de Turiso. Discovery of Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors that Modulate Brain Inflammation In Vivo. Journal of Medicinal Chemistry 2021, 64 (20) , 15402-15419. https://doi.org/10.1021/acs.jmedchem.1c01458
    67. Baichen Xiong, Yuanyuan Wang, Ying Chen, Shuaishuai Xing, Qinghong Liao, Yao Chen, Qi Li, Wei Li, Haopeng Sun. Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective. Journal of Medicinal Chemistry 2021, 64 (18) , 13152-13173. https://doi.org/10.1021/acs.jmedchem.1c00910
    68. Min Guo, Abolghasem Bakhoda, Zhan-Guo Gao, Joseph M. Ramsey, Yang Li, Kelly A. O’Conor, Andrew C. Kelleher, Seth M. Eisenberg, Yeona Kang, Xuefeng Yan, Cameron Javdan, Joanna S. Fowler, Kenner C. Rice, Jacob M. Hooker, Kenneth A. Jacobson, Sung Won Kim, Nora D. Volkow. Discovery of Highly Potent Adenosine A1 Receptor Agonists: Targeting Positron Emission Tomography Probes. ACS Chemical Neuroscience 2021, 12 (18) , 3410-3417. https://doi.org/10.1021/acschemneuro.1c00397
    69. Md. Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, Saeideh Nozohouri, Srinidhi Jayaraman, Nihar Kinarivala, Joanna Kocot, Andrew Baez, Delaney Farris, Thomas J. Abbruscato, Vardan T. Karamyan, Paul C. Trippier. Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability. Journal of Medicinal Chemistry 2021, 64 (17) , 12705-12722. https://doi.org/10.1021/acs.jmedchem.1c00759
    70. Brendan J. Wall, Mark F. Will, Gideon K. Yawson, Paige J. Bothwell, David C. Platt, C. Fiore Apuzzo, Marjorie A. Jones, Gregory M. Ferrence, Michael I. Webb. Importance of Hydrogen Bonding: Structure–Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer’s Disease Therapy. Journal of Medicinal Chemistry 2021, 64 (14) , 10124-10138. https://doi.org/10.1021/acs.jmedchem.1c00360
    71. Mónica García, Virginia Llorente, Lourdes Garriga, Ute Christmann, Sergi Rodríguez-Escrich, Marina Virgili, Begoña Fernández, Magda Bordas, Eva Ayet, Javier Burgueño, Marta Pujol, Albert Dordal, Enrique Portillo-Salido, Georgia Gris, José Miguel Vela, Carmen Almansa. Propionamide Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain. Journal of Medicinal Chemistry 2021, 64 (14) , 10139-10154. https://doi.org/10.1021/acs.jmedchem.1c00417
    72. Dana M. Klug, Eftychia M. Mavrogiannaki, Katherine C. Forbes, Lisseth Silva, Rosario Diaz-Gonzalez, Guiomar Pérez-Moreno, Gloria Ceballos-Pérez, Raquel Garcia-Hernández, Cristina Bosch-Navarrete, Carlos Cordón-Obras, Claudia Gómez-Liñán, Andreu Saura, Jeremiah D. Momper, Maria Santos Martinez-Martinez, Pilar Manzano, Ali Syed, Nelly El-Sakkary, Conor R. Caffrey, Francisco Gamarro, Luis Miguel Ruiz-Perez, Dolores Gonzalez Pacanowska, Lori Ferrins, Miguel Navarro, Michael P. Pollastri. Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis. Journal of Medicinal Chemistry 2021, 64 (13) , 9404-9430. https://doi.org/10.1021/acs.jmedchem.1c00674
    73. Fabio Urbina, Kimberley M. Zorn, Daniela Brunner, Sean Ekins. Comparing the Pfizer Central Nervous System Multiparameter Optimization Calculator and a BBB Machine Learning Model. ACS Chemical Neuroscience 2021, 12 (12) , 2247-2253. https://doi.org/10.1021/acschemneuro.1c00265
    74. Alessandro Bonifazi, Francisco O. Battiti, Julie Sanchez, Saheem A. Zaidi, Eric Bow, Mariia Makarova, Jianjing Cao, Anver Basha Shaik, Agnieszka Sulima, Kenner C. Rice, Vsevolod Katritch, Meritxell Canals, J. Robert Lane, Amy Hauck Newman. Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management. Journal of Medicinal Chemistry 2021, 64 (11) , 7778-7808. https://doi.org/10.1021/acs.jmedchem.1c00611
    75. José Luis Díaz, Félix Cuevas, Ana I. Oliva, Daniel Font, M. Ángeles Sarmentero, Paula Álvarez-Bercedo, José M. López-Valbuena, Miquel A. Pericàs, Raquel Enrech, Ana Montero, Sandra Yeste, Alba Vidal-Torres, Inés Álvarez, Pilar Pérez, Cruz Miguel Cendán, Enrique J. Cobos, José Miguel Vela, Carmen Almansa. Tricyclic Triazoles as σ1 Receptor Antagonists for Treating Pain. Journal of Medicinal Chemistry 2021, 64 (8) , 5157-5170. https://doi.org/10.1021/acs.jmedchem.1c00244
    76. José Jiménez-Luna, Miha Skalic, Nils Weskamp, Gisbert Schneider. Coloring Molecules with Explainable Artificial Intelligence for Preclinical Relevance Assessment. Journal of Chemical Information and Modeling 2021, 61 (3) , 1083-1094. https://doi.org/10.1021/acs.jcim.0c01344
    77. Nandini C. Patel, Bo Feng, Xinjun Hou, Mark A. West, Patrick E. Trapa, Simone Sciabola, Patrick Verhoest, Jennifer L. Liras, Tristan S. Maurer, Travis T. Wager. Harnessing Preclinical Data as a Predictive Tool for Human Brain Tissue Targeting. ACS Chemical Neuroscience 2021, 12 (6) , 1007-1017. https://doi.org/10.1021/acschemneuro.0c00807
    78. Anton Lindberg, Ashley C. Knight, Daniel Sohn, Laszlo Rakos, Junchao Tong, April Radelet, N. Scott Mason, Jeffrey S. Stehouwer, Brian J. Lopresti, William E. Klunk, Johan Sandell, Alexander Sandberg, Per Hammarström, Samuel Svensson, Chester A. Mathis, Neil Vasdev. Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies. ACS Chemical Neuroscience 2021, 12 (4) , 596-602. https://doi.org/10.1021/acschemneuro.0c00801
    79. Jennifer J. Klein, Nancy C. Baker, Daniel H. Foil, Kimberley M. Zorn, Fabio Urbina, Ana C. Puhl, Sean Ekins. Using Bibliometric Analysis and Machine Learning to Identify Compounds Binding to Sialidase-1. ACS Omega 2021, 6 (4) , 3186-3193. https://doi.org/10.1021/acsomega.0c05591
    80. Upul K. Bandarage, Alex M. Aronov, Jingrong Cao, Jon H. Come, Kevin M. Cottrell, Robert J. Davies, Simon Giroux, Marc Jacobs, Sudipta Mahajan, David Messersmith, Cameron S. Moody, Rebecca Swett, Jinwang Xu. Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors. ACS Medicinal Chemistry Letters 2021, 12 (1) , 129-135. https://doi.org/10.1021/acsmedchemlett.0c00573
    81. Thomas O. Schrader, Yifeng Xiong, Ariana O. Lorenzana, Alexander Broadhead, Karin J. Stebbins, Michael M. Poon, Christopher Baccei, Daniel S. Lorrain. Discovery of PIPE-359, a Brain-Penetrant, Selective M1 Receptor Antagonist with Robust Efficacy in Murine MOG-EAE. ACS Medicinal Chemistry Letters 2021, 12 (1) , 155-161. https://doi.org/10.1021/acsmedchemlett.0c00626
    82. Thomas Blaschke, Josep Arús-Pous, Hongming Chen, Christian Margreitter, Christian Tyrchan, Ola Engkvist, Kostas Papadopoulos, Atanas Patronov. REINVENT 2.0: An AI Tool for De Novo Drug Design. Journal of Chemical Information and Modeling 2020, 60 (12) , 5918-5922. https://doi.org/10.1021/acs.jcim.0c00915
    83. Mónica García, Marina Virgili, Mònica Alonso, Carles Alegret, Joan Farran, Begoña Fernández, Magda Bordas, Rosalia Pascual, Javier Burgueño, Alba Vidal-Torres, Antonio R. Fernández de Henestrosa, Eva Ayet, Manuel Merlos, Jose Miguel Vela, Carlos R. Plata-Salamán, Carmen Almansa. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. Journal of Medicinal Chemistry 2020, 63 (24) , 15508-15526. https://doi.org/10.1021/acs.jmedchem.0c01127
    84. Riley D. Kirk, Kassie Picard, Joseph A. Christian, Shelby L. Johnson, Brenton DeBoef, Matthew J. Bertin. Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics. ACS Chemical Neuroscience 2020, 11 (24) , 4478-4488. https://doi.org/10.1021/acschemneuro.0c00686
    85. Albert W. Garofalo, Jessica Bright, Stéphane De Lombaert, Alyssa M. A. Toda, Kerry Zobel, Daniele Andreotti, Claudia Beato, Silvia Bernardi, Federica Budassi, Laura Caberlotto, Peng Gao, Cristiana Griffante, Xinying Liu, Luisa Mengatto, Marco Migliore, Fabio Maria Sabbatini, Anna Sava, Elena Serra, Paolo Vincetti, Mingliang Zhang, Holly J. Carlisle. Selective Inhibitors of G2019S-LRRK2 Kinase Activity. Journal of Medicinal Chemistry 2020, 63 (23) , 14821-14839. https://doi.org/10.1021/acs.jmedchem.0c01243
    86. José Luis Díaz, Mónica García, Antoni Torrens, Ana María Caamaño, Juan Enjo, Cristina Sicre, Adriana Lorente, Adriana Port, Ana Montero, Sandra Yeste, Inés Álvarez, Miquel Martín, Rafael Maldonado, Beatriz de la Puente, Alba Vidal-Torres, Cruz Miguel Cendán, José Miguel Vela, Carmen Almansa. EST64454: a Highly Soluble σ1 Receptor Antagonist Clinical Candidate for Pain Management. Journal of Medicinal Chemistry 2020, 63 (23) , 14979-14988. https://doi.org/10.1021/acs.jmedchem.0c01575
    87. William Mahy, Nicky J. Willis, Yuguang Zhao, Hannah L. Woodward, Fredrik Svensson, James Sipthorp, Luca Vecchia, Reinis R. Ruza, James Hillier, Svend Kjær, Sarah Frew, Amy Monaghan, Magda Bictash, Patricia C. Salinas, Paul Whiting, Jean-Paul Vincent, E. Yvonne Jones, Paul V. Fish. 5-Phenyl-1,3,4-oxadiazol-2(3H)-ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit. Journal of Medicinal Chemistry 2020, 63 (21) , 12942-12956. https://doi.org/10.1021/acs.jmedchem.0c01391
    88. Carmen Esposito, Shuzhe Wang, Udo E. W. Lange, Frank Oellien, Sereina Riniker. Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein Substrates. Journal of Chemical Information and Modeling 2020, 60 (10) , 4730-4749. https://doi.org/10.1021/acs.jcim.0c00525
    89. James A. Lumley, Prashant Desai, Jibo Wang, Suntara Cahya, Hongzhou Zhang. The Derivation of a Matched Molecular Pairs Based ADME/Tox Knowledge Base for Compound Optimization. Journal of Chemical Information and Modeling 2020, 60 (10) , 4757-4771. https://doi.org/10.1021/acs.jcim.0c00583
    90. Marta Serafini, Sarah Cargnin, Alberto Massarotti, Tracey Pirali, Armando A. Genazzani. Essential Medicinal Chemistry of Essential Medicines. Journal of Medicinal Chemistry 2020, 63 (18) , 10170-10187. https://doi.org/10.1021/acs.jmedchem.0c00415
    91. Christopher P. Tinworth, Robert J. Young. Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data. Journal of Medicinal Chemistry 2020, 63 (18) , 10091-10108. https://doi.org/10.1021/acs.jmedchem.9b01596
    92. William Mahy, Mikesh Patel, David Steadman, Hannah L. Woodward, Benjamin N. Atkinson, Fredrik Svensson, Nicky J. Willis, Alister Flint, Dimitra Papatheodorou, Yuguang Zhao, Luca Vecchia, Reinis R. Ruza, James Hillier, Sarah Frew, Amy Monaghan, Artur Costa, Magda Bictash, Magnus W. Walter, E. Yvonne Jones, Paul V. Fish. Screening of a Custom-Designed Acid Fragment Library Identifies 1-Phenylpyrroles and 1-Phenylpyrrolidines as Inhibitors of Notum Carboxylesterase Activity. Journal of Medicinal Chemistry 2020, 63 (17) , 9464-9483. https://doi.org/10.1021/acs.jmedchem.0c00660
    93. Duncan E. Scott, Timothy P. C. Rooney, Elliott D. Bayle, Tashfina Mirza, Henriette M. G. Willems, Jonathan H. Clarke, Stephen P. Andrews, John Skidmore. Systematic Investigation of the Permeability of Androgen Receptor PROTACs. ACS Medicinal Chemistry Letters 2020, 11 (8) , 1539-1547. https://doi.org/10.1021/acsmedchemlett.0c00194
    94. Scott H. Henderson, Fiona Sorrell, James Bennett, Marcus T. Hanley, Sean Robinson, Iva Hopkins Navratilova, Jonathan M. Elkins, Simon E. Ward. Mining Public Domain Data to Develop Selective DYRK1A Inhibitors. ACS Medicinal Chemistry Letters 2020, 11 (8) , 1620-1626. https://doi.org/10.1021/acsmedchemlett.0c00279
    95. Eric A. Wold, Erik J. Garcia, Christopher T. Wild, Joanna M. Miszkiel, Claudia A. Soto, Jianping Chen, Konrad Pazdrak, Robert G. Fox, Noelle C. Anastasio, Kathryn A. Cunningham, Jia Zhou. Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties. Journal of Medicinal Chemistry 2020, 63 (14) , 7529-7544. https://doi.org/10.1021/acs.jmedchem.9b01953
    96. Payal Rana, Stephen Kogut, Xuerong Wen, Fatemeh Akhlaghi, Michael D. Aleo. Most Influential Physicochemical and In Vitro Assay Descriptors for Hepatotoxicity and Nephrotoxicity Prediction. Chemical Research in Toxicology 2020, 33 (7) , 1780-1790. https://doi.org/10.1021/acs.chemrestox.0c00040
    97. Xiawei Dang, Lihong Zhang, Antonietta Franco, Jiajia Li, Agostinho G. Rocha, Sriram Devanathan, Roland E. Dolle, Peter R. Bernstein, Gerald W. Dorn, II. Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases. Journal of Medicinal Chemistry 2020, 63 (13) , 7033-7051. https://doi.org/10.1021/acs.jmedchem.0c00366
    98. Xiaoyu Zang, Leila Peraro, Ryan T. Davison, Travis R. Blum, Deepak Vallabhaneni, Caitlyn E. Fennell, Stephanie L. Cramer, Heli K. Shah, Deirdre M. Wholly, Elissa A. Fink, Jacob T. Sivak, Kathryn M. Ingalls, Chelsea T. Herr, Vernon E. Lawson, Matthew R. Burnett, David J. Slade, Kathryn E. Cole, Sigrid A. Carle, Justin S. Miller. Synthesis and Biological Evaluation of a Depsipeptidic Histone Deacetylase Inhibitor via a Generalizable Approach Using an Optimized Latent Thioester Solid-Phase Linker. The Journal of Organic Chemistry 2020, 85 (12) , 8253-8260. https://doi.org/10.1021/acs.joc.0c00854
    99. Kevin G. Liu, Ji-In Kim, Kellen Olszewski, Anthony M. Barsotti, Koi Morris, Christophe Lamarque, Xuemei Yu, Jack Gaffney, Xiao-Jiang Feng, Jeegar P. Patel, Masha V. Poyurovsky. Discovery and Optimization of Glucose Uptake Inhibitors. Journal of Medicinal Chemistry 2020, 63 (10) , 5201-5211. https://doi.org/10.1021/acs.jmedchem.9b02153
    100. Jana Maříková, Aneta Ritomská, Jan Korábečný, Rozálie Peřinová, Abdullah Al Mamun, Tomáš Kučera, Eliška Kohelová, Daniela Hulcová, Tereza Kobrlová, Jiří Kuneš, Lucie Nováková, Lucie Cahlíková. Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase. Journal of Natural Products 2020, 83 (5) , 1359-1367. https://doi.org/10.1021/acs.jnatprod.9b00561
    Load more citations